From: Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Label | Levels | Genistein | Placebo | p |
---|---|---|---|---|
Age | Mean (SD) | 66.5 (7.2) | 69.8 (5.9) | 0.206 |
Sex | Female | 6 (42.9) | 3 (23.1) | 0.496 |
Male | 8 (57.1) | 10 (76.9) | ||
Education | Primary | 9 (64.3) | 4 (30.8) | 0.149 |
Secondary | 1 (7.1) | 4 (30.8) | ||
University | 4 (28.6) | 5 (38.5) | ||
ApoE | 2/4 | 0 (0.0) | 1 (7.7) | 0.555 |
3/4 | 5 (35.7) | 6 (46.2) | ||
4/4 | 9 (64.3) | 6 (46.2) | ||
MEC | Median (IQR) | 22 (3.5) | 25 (3) | 0.077 |